Real-time enrollment status for this homocystinuria due to cbs deficiency clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:25 PM UTC
| NCT Number | NCT02998710 |
| Recruiting Status | Recruiting |
| Condition | Homocystinuria Due to CBS Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Travere Therapeutics, Inc. |
| Last Updated on CT.gov | November 22, 2024 (Nov 22, 2024) |
As of August 27, 2026: Clinical trial NCT02998710 is currently recruiting participants. This clinical trial study for homocystinuria due to cbs deficiency is actively seeking new participants at 7 locations across the United States. The study is sponsored by Travere Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02998710 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02998710 was last updated Nov 22, 2024 (November 22, 2024). HelloStudys verifies this status automatically.